Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Stress echo 2030 : The novel ABCDE-(FGLPR) protocol to define the future of imaging. / Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging.
в: Journal of Clinical Medicine, Том 10, № 16, 3641, 17.08.2021.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Stress echo 2030
T2 - The novel ABCDE-(FGLPR) protocol to define the future of imaging
AU - Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging
AU - Picano, Eugenio
AU - Ciampi, Quirino
AU - Cortigiani, Lauro
AU - Arruda-Olson, Adelaide M.
AU - Borguezan-Daros, Clarissa
AU - Pretto, José Luis De Castro E.Silva
AU - Cocchia, Rosangela
AU - Bossone, Eduardo
AU - Merli, Elisa
AU - Kane, Garvan C.
AU - Varga, Albert
AU - Agoston, Gergely
AU - Scali, Maria Chiara
AU - Morrone, Doralisa
AU - Simova, Iana
AU - Samardjieva, Martina
AU - Boshchenko, Alla
AU - Ryabova, Tamara
AU - Vrublevsky, Alexander
AU - Palinkas, Attila
AU - Palinkas, Eszter D.
AU - Sepp, Robert
AU - Torres, Marco A.R.
AU - Villarraga, Hector R.
AU - Preradović, Tamara Kovačević
AU - Citro, Rodolfo
AU - Amor, Miguel
AU - Mosto, Hugo
AU - Salamè, Michael
AU - Leeson, Paul
AU - Mangia, Cristina
AU - Gaibazzi, Nicola
AU - Tuttolomondo, Domenico
AU - Prota, Costantina
AU - Peteiro, Jesus
AU - Van De Heyning, Caroline M.
AU - D'Andrea, Antonello
AU - Rigo, Fausto
AU - Nikolic, Aleksandra
AU - Ostojic, Miodrag
AU - Lowenstein, Jorge
AU - Arbucci, Rosina
AU - Lowenstein Haber, Diego M.
AU - Merlo, Pablo M.
AU - Wierzbowska-Drabik, Karina
AU - Kasprzak, Jaroslaw D.
AU - Haberka, Maciej
AU - Camarozano, Ana Cristina
AU - Ratanasit, Nithima
AU - Zagatina, Angela
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8/17
Y1 - 2021/8/17
N2 - With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
AB - With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
KW - Effectiveness
KW - Registry
KW - Stress echocardiography
KW - Sustainability
KW - effectiveness
KW - registry
KW - PRESERVED EJECTION FRACTION
KW - GRADIENT AORTIC-STENOSIS
KW - HEART-RATE RESERVE
KW - sustainability
KW - EUROPEAN ASSOCIATION
KW - PROGNOSTIC VALUE
KW - HYPERTROPHIC CARDIOMYOPATHY
KW - FLOW RESERVE
KW - stress echocardiography
KW - DESCENDING CORONARY-ARTERY
KW - EXPERT CONSENSUS
KW - AMERICAN SOCIETY
UR - http://www.scopus.com/inward/record.url?scp=85113778069&partnerID=8YFLogxK
U2 - 10.3390/jcm10163641
DO - 10.3390/jcm10163641
M3 - Article
AN - SCOPUS:85113778069
VL - 10
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
SN - 2077-0383
IS - 16
M1 - 3641
ER -
ID: 85561058